Overview of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Webinar | September 25, 2019 10:00 pm to 11:00 pm EST
You must be logged in to PKDnetwork to register for this event.

No PKDnetwork account?
Create one now - it's free!

Our events are free but require a username and password to register. To register for this event, log in to your account or create a new account for free using the buttons below!

Description

Please join us for a free webinar, led by PKD experts from across the country, where you can hear the most current information on ADPKD pathophysiology, disease progression, and the physical & emotional burden of ADPKD.

Objectives:

  • Review of the recent advancements made in the ADPKD field
  • Address key factors that play into ADPKD disease progression
  • Highlight and evaluate prognostic indicators of advanced ADPKD outcomes
View Flyer (PDF)

Event Speakers

Neera Dahl, MD, PhD*
Associate Professor of Medicine, Nephrology Yale School of Medicine

Dr. Neera Dahl is currently a clinician-educator and an Associate Professor at Yale University, School of Medicine, Section of Nephrology. She received her MD and PhD from Tufts University School of Medicine, and completed her residency and fellowship at the Beth Israel Deaconess Medical Center, in Boston, MA. She has been at Yale since 2007. She has been instrumental in developing the Yale Inherited Kidney Disease Clinical Program, and is the principal investigator for several ongoing clinical trials in ADPKD. She maintains an active ADPKD registry and is involved in research exploring the role of inflammation and fibrosis in the progression of ADPKD. She is also the director of the Yale Nephrology Clinical Trials Program and a member of the Scientific Advisory Board for the Polycystic Kidney Disease Foundation.


Arlene Chapman, MD*
Chief Department of Medicine, Nephrology Professor of Medicine, Nephrology University of Chicago

Dr. Chapman is the section chief of nephrology at the University of Chicago and the director of the Clinical Research Center for the University of Chicago’s Institute for Translational Medicine.

Dr. Chapman attended medical school at MacMaster School of Medicine in Ontario, Canada, followed by training in Internal Medicine at Georgetown University School of Medicine in Washington, DC and a fellowship in Renal Medicine at the University of Colorado School of Medicine. She joined the University of Colorado faculty as an Assistant Professor and was later promoted to Associate Professor. She then joined the faculty at Emory University, where she was promoted to Professor of Medicine and later accepted the role of section chief of Nephrology at the University of Chicago.

Dr. Chapman’s research focuses on mechanisms of cyst formation in autosomal dominant polycystic kidney disease. She has been integrally involved in the development of novel imaging biomarkers for this disease. In addition, her career has focused on other rare conditions including ARPKD, the CAKUT disorders, ciliopathies, tuberous sclerosis complex and von Hippel Lindau disease.

Her academic contributions include membership on several NIH committees as well as the Scientific Advisory Council for the Polycystic Kidney Disease Research Foundation and the Council for the American Kidney Societies. She has also served on the editorial boards for JASN, CJASN, AJKD, Kidney International, and NDT.


The registration for this event is now closed.